Making General Internal Medicine Research Relevant to the Older Patient with Multiple Chronic Comorbidities
General Internal Medicine research evolves in response to the needs of the patients to whom we provide care. Currently, many studies exclude older adults who deeply affect the clinical care of this population. With the number of older adults increasing, creating research protocols that include older adults with multiple chronic comorbidities is imperative. Through funding from the Association of Specialty Physicians, a working group of aging-responsive researchers from the Society of General Internal Medicine was convened to tackle this issue. The goal of this article is threefold: 1) to shed light on the current exclusion of older adults in research; 2) to identify and propose research protocol solutions for overcoming barriers to including older adults in research; and 3) to provide suggestions for research funding. The extent to which these recommendations can create change depends greatly on our researcher colleagues. By embracing these challenges, we hope that the care provided to older adults with multiple chronic conditions will no longer be extrapolated, but become evidence-based.
- 4.Agency for Healthcare Research and Quality. AHRQ Policy on the Inclusion of Priority Populations in Research. US Department of Health and Human Services; 2003.Google Scholar
- 5.US Government Accountability Office. Prescription drugs: FDA guidance and regulations related to data on elderly persons in clinical drug trials (GAO-07-47R). Washington, D.C.; 2007.Google Scholar
- 9.U.S. Department of Health & Human Services; Code of Federal Regulations, Title 45 – Public Welfare, Part 46 – Protection of Human Subjects. 45 CFR 46.116. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html. (Accessed Sept. 27, 2013).
- 10.Health and Retirement Study: Sample sizes and response rates. Available at: http://hrsonline.isr.umich.edu/sitedocs/sampleresponse.pdf. (Accessed Sept. 27, 2013).
- 17.Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9. Available at http://www.mocatest.org/ (accessed Sept.27, 2013).PubMedCrossRefGoogle Scholar
- 20.Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. Columbia Univ Press; 1949. P.196.Google Scholar